三叉神经痛的立体定向放射外科治疗:近端与远端等中心靶点疗效比较
这项多中心回顾性分析纳入2017至2021年接受伽玛刀或直线加速器立体定向放射外科治疗的三叉神经痛患者86例,比较近端与远端等中心靶点的疗效。近端靶向组总体疼痛缓解率为74%、完全缓解率为46%,远端靶向组分别为90%和31%(完全缓解率比较P=.011);近端靶向组完全停药更常见(39% vs 13%),远端靶向组部分减药更常见(75% vs 33%)(P=.001)。作者认为远端靶向可能与更高的任何疼痛改善率相关,近端靶向可能与更高的完全疼痛缓解率和完全停药率相关,这些发现具有假设生成性,需进一步研究。
要点
- 近端靶向组完全疼痛缓解率为46%,远端靶向组为31%(P=.011)。
- 近端靶向组总体疼痛缓解率为74%,远端靶向组为90%。
- 近端靶向组完全停药率39% vs 远端靶向组13%,部分减药率33% vs 75%(P=.001)。
核心结论
- 近端与远端靶向方法均获得较高的三叉神经痛应答率。
- 远端靶向可能与更高的任何疼痛改善率相关,近端靶向可能与更高的完全疼痛缓解率和完全停药率相关。
- 作者认为这些发现具有假设生成性,需进一步研究两种方法在疗效和安全性上的差异。
研究设计与样本
- 多中心回顾性分析,纳入2017至2021年接受伽玛刀或直线加速器立体定向放射外科治疗且随访至少1年的三叉神经痛患者。
- 共纳入86例患者,54例(63%)接受近端靶向(中位年龄63岁,72%为女性),32例(37%)接受远端靶向(中位年龄66岁,71%为女性)。
- 所有患者处方剂量均为85 Gy至等中心,靶点位于背根进入区(近端)或三叉神经节后区(远端)。
主要发现
- 总体疼痛缓解率:近端靶向组74%,远端靶向组90%。
- 完全疼痛缓解率:近端靶向组46%,远端靶向组31%(P=.011)。
- 疼痛缓解持续时间两组间无显著差异(P=.18)。
- 完全停药率:近端靶向组39% vs 远端靶向组13%;部分减药率:近端靶向组33% vs 远端靶向组75%(P=.001)。
局限性
- 作者指出这些发现具有假设生成性,需进一步研究两种方法在疗效和安全性上的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adv Radiat Oncol . 2026 Sep 17;12(1):102220. doi: 10.1016/j.adro.2026.102220. eCollection 2027 Jan. ABSTRACT PURPOSE: Trigeminal neuralgia (TN) is a chronic neuropathic pain condition affecting the trigeminal nerve, with an incidence of approximately 4 to 5 per 100,000 persons annually, increasing to 20 per 100,000 after age 60 years, and a female-to-male ratio of approximately 3:2. Stereotactic radiosurgery (SRS) delivered by Gamma Knife or linear accelerators is a noninvasive alternative to surgical approaches for medically refractory cases. Although SRS for TN is commonly performed, consensus regarding optimal anatomic targeting remains lacking, with the 2 most common targets being the dorsal root entry zone (proximal) and the retrogasserian zone (distal). This study aimed to evaluate treatment outcomes in patients with TN treated with SRS based on proximal versus distal isocenter target locations. METHODS AND MATERIALS: This multicenter retrospective analysis included patients treated for TN between 2017 and 2021 with Gamma Knife or linear accelerator-based SRS who were followed for at least 1 year. All patients received 85 Gy prescribed to the isocenter, located in either the dorsal root entry zone (proximal) or the retrogasserian zone (distal). Patient-reported pain relief was recorded as complete, partial, or absent. Duration of pain relief and medication de-escalation were also assessed. Outcomes were compared using the log-rank test and Cox proportional hazards analysis. RESULTS: Eighty-six patients were included: 54 of 86 (63%) treated with proximal targeting (median age, 63 years; 72% women) and 32 of 86 (37%) with distal targeting (median age, 66 years; 71% women). Overall pain relief rates were 74% (proximal) and 90% (distal), although complete pain relief rates were 46% (proximal) and 31% (distal) ( p = .011). Duration of pain relief did not differ significantly between groups ( p = .18). Complete medication de-escalation was more frequent with proximal targeting (39% vs 13%), although partial de-escalation was more common with distal targeting (75% vs 33%) ( P = .001). CONCLUSIONS: Both proximal and distal targeting approaches achieve high response rates for TN. Distal targeting may be associated with higher rates of any pain improvement, whereas proximal targeting may be associated with higher rates of complete pain relief and complete medication discontinuation. These findings are hypothesis-generating and warrant further investigation of efficacy and safety differences between these 2 approaches.
引用
- PubMed 顶刊 · 中枢神经:Stereotactic Radiosurgery for Trigeminal Neuralgia: A Comparison of Proximal and Distal Isocenter Outcomes
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。